Utah 2025 Regular Session

Utah House Bill HB0052 Latest Draft

Bill / Substitute Version Filed 02/11/2025

                            02-11 15:21	2nd Sub. (Gray) H.B. 52
Candice B. Pierucci proposes the following substitute bill:
1 
Health Insurance Modifications
2025 GENERAL SESSION
STATE OF UTAH
Chief Sponsor: Candice B. Pierucci
Senate Sponsor:
2 
 
3 
LONG TITLE
4 
General Description:
5 
This bill enacts provisions related to health insurance.
6 
Highlighted Provisions:
7 
This bill:
8 
▸ defines terms;
9 
▸ requires an insurer to calculate drug or device discount coupons on behalf of an individual
10 
towards the individual's cost sharing requirement unless certain circumstances are met;
11 
▸ requires a entity that provides a drug or device discount coupon to allow the full amount
12 
of the coupon amount to be used for the drug or device; and
13 
▸ provides an exception to the requirements for a qualifying health benefit plan.
14 
Money Appropriated in this Bill:
15 
None
16 
Other Special Clauses:
17 
None
18 
Utah Code Sections Affected:
19 
ENACTS:
20 
31A-22-662, Utah Code Annotated 1953
21 
31A-48-104, Utah Code Annotated 1953
22 
 
23 
Be it enacted by the Legislature of the state of Utah:
24 
Section 1.  Section 31A-22-662 is enacted to read:
25 
31A-22-662 . Cost sharing requirements for health benefit plans.
26 
(1) As used in this section:
27 
(a) "Biosimilar" means a biological product, as defined in 42 U.S.C. Sec. 262, that is
28 
highly similar to another biological product.
2nd Sub. H.B. 52 2nd Sub. (Gray) H.B. 52	02-11 15:21
29 
(b)(i) "Cost sharing requirement" means any copayment, coinsurance, deductible, or
30 
annual limitation on cost sharing required by a health benefit plan for a specific
31 
health care service covered by the health benefit plan.
32 
(ii) "Cost sharing requirement" includes any copayment, coinsurance, deductible, or
33 
annual limitation that is subject to 42 U.S.C. Sec. 18022(c) or 300gg-6(b).
34 
(c) "Qualifying health benefit plan" means a health benefit plan that:
35 
(i) allows the full value of available copay assistance to reduce the out-of-pocket
36 
costs of an enrollee;
37 
(ii) includes, when two or more individuals are covered, an individual maximum
38 
out-of-pocket that is not greater than 50% of the health benefit plan's combined
39 
total maximum out-of-pocket for family coverage;
40 
(iii) after the deductible has been met, only requires payment by the enrollee at the
41 
equivalent of the plan's lowest payment tier for any drug that has been subject to
42 
copay assistance and that copay assistance has been exhausted; and
43 
(iv) for a covered lower cost drug that an enrollee is required to take under the plan
44 
instead of a covered higher cost drug for which copay assistance reduces the
45 
enrollee's out-of-pocket costs to a negligible amount, the plan:
46 
(A) only requires payment by the enrollee of the preferred drug at the equivalent
47 
of the plan's lowest payment tier; and
48 
(B) may share cost savings due to the lower cost drug with the enrollee, including
49 
while the enrollee is subject to a deductible.
50 
(2) Except as provided in Subsection (3), when calculating an enrollee's contribution to any
51 
applicable cost sharing requirement for a covered prescription drug or device, an insurer
52 
shall include any cost sharing amounts paid:
53 
(a) by the enrollee; or
54 
(b) using a drug discount coupon.
55 
(3) An insurer may refuse to apply a drug discount coupon to an enrollee's applicable cost
56 
sharing requirement for the drug or device that is eligible for the drug discount coupon if:
57 
(a) the drug or device that is eligible for the drug discount coupon has:
58 
(i) a generic alternative; or
59 
(ii) a biosimilar that:
60 
(A) has been approved by the federal Food and Drug Administration to treat the
61 
enrollee's condition;
62 
(B) is not eligible for a drug discount coupon; and
- 2 - 02-11 15:21	2nd Sub. (Gray) H.B. 52
63 
(C) is subject to the health benefit plan's lowest copay tier for biologic products; or
64 
(b) the enrollee has not obtained a necessary approval from the health benefit plan to
65 
have the drug covered by the health benefit plan or has not completed the necessary
66 
requirements, restrictions, or clinical criteria to obtain the approval.
67 
(4) This section:
68 
(a) applies to any health benefit plan entered into, amended, extended, or renewed on or
69 
after July 1, 2026; and
70 
(b) does not apply to a qualifying health benefit plan.
71 
(5) The commissioner may make rules in accordance with Title 63G, Chapter 3, Utah
72 
Administrative Rulemaking Act, to implement this section.
73 
(6) The department shall enforce this section within existing appropriations.
74 
Section 2.  Section 31A-48-104 is enacted to read:
75 
31A-48-104 . Drug discount coupon requirements.
76 
(1) As used in this section, "cost sharing requirement" means the same as that term is
77 
defined in Section 31A-22-662.
78 
(2) A pharmaceutical manufacturer or other entity that provides a drug discount coupon
79 
with the expectation that the drug discount coupon will be applied toward an enrollee's
80 
cost sharing requirement:
81 
(a) shall allow an insurer, complying with Section 31A-22-662, to utilize the full value
82 
of the drug discount coupon:
83 
(i) first to reduce the enrollee's cost sharing requirement, including the enrollee's
84 
maximum out-of-pocket expense, at the point of sale; and
85 
(ii) for any remainder, to lower the cost of the prescription drug or device;
86 
(b) shall disclose to the insurer the terms and conditions associated with the drug
87 
discount coupon at least 12 months before a drug discount coupon is issued; and
88 
(c) may not modify the terms and conditions associated with the drug discount coupon
89 
on the basis that it is redeemed by an enrollee of the health benefit plan that is
90 
complying with Section 31A-22-662.
91 
(3) The department shall enforce this section within existing appropriations.
92 
Section 3.  Effective Date.
93 
This bill takes effect on May 7, 2025.
- 3 -